Nyxoah SA Cash Flow from Financial Activities 2021-2025 | NYXH
Nyxoah SA cash flow from financial activities from 2021 to 2025. Cash flow from financial activities can be defined as the net amount of cash transactions used in funding activities
| Nyxoah SA Annual Cash Flow Financial (Millions of US $) |
|
|---|---|
| 2024 | $84 |
| 2023 | $18 |
| 2022 | $-1 |
| 2021 | $90 |
| 2020 | $119 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.260B | $0.005B |
| Nyxoah SA is a medical technology company. It focused on the development and commercialization of solutions to treat Obstructive Sleep Apnea. Nyxoah SA is based in Belgium. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $45.332B | 57.93 |
| Hims & Hers Health (HIMS) | United States | $12.707B | 132.02 |
| Tempus AI (TEM) | United States | $10.988B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $4.490B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $3.944B | 61.63 |
| Hinge Health (HNGE) | United States | $3.156B | 0.00 |
| Privia Health (PRVA) | United States | $2.783B | 190.25 |
| Enovis (ENOV) | United States | $1.694B | 9.44 |
| Clover Health Investments (CLOV) | United States | $1.613B | 0.00 |
| Schrodinger (SDGR) | United States | $1.592B | 0.00 |
| Phreesia (PHR) | United States | $1.482B | 0.00 |
| Omnicell (OMCL) | United States | $1.415B | 24.96 |
| Azenta (AZTA) | United States | $1.219B | 56.66 |
| 10x Genomics (TXG) | United States | $1.164B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.629B | 0.00 |
| Claritev (CTEV) | United States | $0.629B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.571B | 0.00 |
| Talkspace (TALK) | United States | $0.561B | 167.50 |
| Veradigm (MDRX) | United States | $0.466B | 0.00 |
| Standard BioTools (LAB) | United States | $0.399B | 0.00 |
| TruBridge (TBRG) | United States | $0.357B | 791.67 |
| Outset Medical (OM) | United States | $0.316B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.264B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.194B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.136B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.129B | 0.00 |
| Pulmonx (LUNG) | United States | $0.126B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.104B | 0.00 |
| American Well (AMWL) | United States | $0.103B | 0.00 |
| CareCloud (CCLD) | United States | $0.085B | 3.26 |
| 111 (YI) | China | $0.070B | 0.00 |
| HeartBeam (BEAT) | United States | $0.061B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.051B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.034B | 0.00 |
| Zhongchao (ZCMD) | China | $0.030B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.026B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.022B | 0.00 |
| Precipio (PRPO) | United States | $0.016B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.016B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.010B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.010B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.008B | 0.00 |
| Movano (MOVE) | United States | $0.004B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.000B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |